Given that elevated ROS appeared to be a robust inducer of ALT activity in ATRX-null cells, it was next considered whether any other genetic events which naturally occur concurrently with ATRX mutations in tumours that are frequently ALT-positive might exert their effect via generation of ROS. The gene discussed is ATRX; the disease is neoplasm.